Targeting chemokines in aortic aneurysm: could this be key to a novel therapy for a common problem?

Golledge, Jonathan (2013) Targeting chemokines in aortic aneurysm: could this be key to a novel therapy for a common problem? Arteriosclerosis, Thrombosis and Vascular Biology, 33. pp. 670-672.

[img] PDF (Published Version) - Published Version
Restricted to Repository staff only

View at Publisher Website: http://dx.doi.org/10.1161/ATVBAHA.112.30...
 
9
6


Abstract

Aortic aneurysm rupture and aortic dissection are important causes of death. In the last decade, several developments have improved the outlook for patients with aortic diseases, including the introduction of ultrasound screening for abdominal aortic aneurysm (AAA) in some countries; more detailed ways of imaging the aorta and the development and subsequent sophisticated advancement of technology to repair large aortic aneurysms via endovascular means. An important remaining challenge is the development of an effective range of medications, which limit the progression of aortic aneurysms and dissections.

Item ID: 39267
Item Type: Article (Editorial)
ISSN: 1524-4636
Keywords: aortic aneurysm; chemokine; CCL5
Funders: Queensland Government, National Health and Medical Research Council of Australia (NHMRC)
Projects and Grants: NHMRC Practitioner Fellowship 1019921
Date Deposited: 16 Jul 2015 01:58
FoR Codes: 11 MEDICAL AND HEALTH SCIENCES > 1102 Cardiovascular Medicine and Haematology > 110201 Cardiology (incl Cardiovascular Diseases) @ 100%
SEO Codes: 92 HEALTH > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions) > 920103 Cardiovascular System and Diseases @ 100%
Downloads: Total: 6
More Statistics

Actions (Repository Staff Only)

Item Control Page Item Control Page